Opportunities and Risks of a Single-Trial Default for FDA Drug Approval

This Viewpoint describes potential concerns and opportunities with a single-trial default for US Food and Drug Administration (FDA) drug approval.

from JAMA Health Forum New Online https://ift.tt/RfsE7qn

Comments

Popular posts from this blog

Skilled Nursing Facilities and Sufficient Bed Capacity